Project Grant HT94252410993
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$464K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
The University of California, Davis was awarded a $483,000 Project Grant from the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING DRUG-TOLERANT PERSISTER CELLS IN OVARIAN CANCER." The award period is from April 1, 2024 to March 31, 2026. The objective of this research project is to develop new treatments for ovarian cancer by targeting drug-tolerant persister cells. As a major public research university, UC...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,178,136.00 to The Trustees of the University of Pennsylvania to conduct research on exploiting the absence of TP53 mutations in epithelial ovarian cancer using next-generation p53-stabilizing agents. The research aims to transform healthcare for military service members and the broader public by advancing innovative approaches to disease...
This federal Project Grant award, totaling $1,163,420.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Davis. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate functional and phenotypic metabolic transitions governing disease state in clear cell renal cell...
This $466,500 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research by The Washington University to leverage the ovarian tumor microenvironment for early detection strategies. The award, effective August 1, 2025 through July 31, 2027, will fund innovative biomedical research focused on transforming healthcare for military service members and the public. The research aims to develop...
This $1,305,270 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports the "Ovarian Cancer Academy: Advancing Ovarian Cancer Research through Mentorship, Networking, and Collaborations" initiative led by The Trustees of the University of Pennsylvania. The award aims to transform healthcare for military service members and the general public through innovative biomedical research in...
The University of California, Davis was awarded a $1,177,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research to target a key tumor plasticity driver in lethal prostate cancer. Through August 2021 to July 2024, UC Davis researchers will investigate medical solutions for prostate cancer on the cellular level with the aim of transforming patient care and outcomes. The...
This Project Grant award for $699,750 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Washington aims to support the discovery and characterization of tissue-specific regulatory mutations that predispose to ovarian cancer. The award will fund research activities over a 3-year period from April 2024 to March 2027. As a leading research university, the University of Washington has extensive experience managing federal grants and...
The University of California, San Francisco (UCSF) was awarded a $6,778,819 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will fund a 4-year research project to conduct low-pass whole-genome sequencing to improve breast cancer risk assessment in a diverse population. UCSF will serve as the prime awardee, with the University of Chicago receiving a sub-award to contribute...
The U.S. Department of the Army Medical Command has awarded a $592,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of California, San Diego (UCSD) to develop a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy". This 3-year research project, running from February 1, 2025 to January 31, 2028, aims to advance innovative biomedical solutions for military personnel and the general public by investigating...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...